rs9485372
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001292035.3(TAB2):c.6+68962G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 152,064 control chromosomes in the GnomAD database, including 3,265 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 3265 hom., cov: 32)
Consequence
TAB2
NM_001292035.3 intron
NM_001292035.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.13
Publications
56 publications found
Genes affected
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2 Gene-Disease associations (from GenCC):
- chromosome 6q24-q25 deletion syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- congenital heart defects, multiple types, 2Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- polyvalvular heart disease syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.412 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TAB2 | NM_001292035.3 | c.6+68962G>A | intron_variant | Intron 2 of 6 | NP_001278964.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TAB2 | ENST00000606202.1 | c.-121+68962G>A | intron_variant | Intron 1 of 1 | 4 | ENSP00000476139.1 |
Frequencies
GnomAD3 genomes AF: 0.200 AC: 30453AN: 151946Hom.: 3267 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
30453
AN:
151946
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.200 AC: 30465AN: 152064Hom.: 3265 Cov.: 32 AF XY: 0.201 AC XY: 14972AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
30465
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
14972
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
8383
AN:
41472
American (AMR)
AF:
AC:
2760
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
836
AN:
3466
East Asian (EAS)
AF:
AC:
2208
AN:
5168
South Asian (SAS)
AF:
AC:
1040
AN:
4820
European-Finnish (FIN)
AF:
AC:
1914
AN:
10552
Middle Eastern (MID)
AF:
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12537
AN:
67998
Other (OTH)
AF:
AC:
443
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1223
2447
3670
4894
6117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1147
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.